1. Alexandrie, A. K., Ingelman Sundberg, M., Seidegard, J., Tornling, G. & Rannung, A. (1994). Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15: 1785–1790.
2. Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J. & Hetzel, M. R. (1984). Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 312: 169–170.
3. Bennett, W. P., Colby, T. V., Travis, W. D., Borkowski, A., Jones, R. T., Lane, D. P., Metcalf, R. A., Samet, J. M., Takeshima, Y., Gu, J. R., Vahakangas, K. H., Soini, Y., Paakko, P., Welsh, J. A., Trump, B. F. & Harris, C. C. (1993). p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 53: 4817–4822.
4. Bennett, W. P., El-Deiry, W. S., Guinee, D. G., Freedman, A. N., Rush, W. L., Caporaso, N. E., Welsh, J. A., Jones, R. T., Borkowski, A., Travis, W. D., Fleming, M. V., Trastek, V., Pairolero, P. C., Tazelaar, H. D., Midthun, D., Jett, J. R., Liotta, L. A. & Harris, C. C. (1998). p21waf1/cip1 and transforming growth factor β1 protein expression correlate with survival in non-small cell lung cancer. Clin Cancer Res 4: 1499–1506.
5. Caporaso, N., Hayes, R. B., Dosemeci, M., Hoover, R., Ayesh, R., Hetzel, M. & Idle, J. (1989). Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res 49: 3675–3679.